Does ROPINIROLE Cause Interstitial lung disease? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Interstitial lung disease have been filed in association with ROPINIROLE (ropinirole hydrochloride). This represents 0.2% of all adverse event reports for ROPINIROLE.
7
Reports of Interstitial lung disease with ROPINIROLE
0.2%
of all ROPINIROLE reports
1
Deaths
2
Hospitalizations
How Dangerous Is Interstitial lung disease From ROPINIROLE?
Of the 7 reports, 1 (14.3%) resulted in death, 2 (28.6%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for ROPINIROLE.
What Other Side Effects Does ROPINIROLE Cause?
Drug ineffective (452)
Hallucination (303)
Somnolence (256)
Nausea (244)
Fall (239)
Dyskinesia (223)
Parkinson's disease (218)
Condition aggravated (200)
Dizziness (194)
Insomnia (192)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ROPINIROLE Alternatives Have Lower Interstitial lung disease Risk?
ROPINIROLE vs ROPIVACAINE
ROPINIROLE vs ROSIGLITAZONE
ROPINIROLE vs ROSUVASTATIN
ROPINIROLE vs ROSUVASTATIN\ROSUVASTATIN
ROPINIROLE vs ROTIGOTINE